4182
H. A. Dondas, N. De Kimpe / Tetrahedron Letters 46 (2005) 4179–4182
8. Frederickson, M.; Grigg, R. Org. Prep. Proced. Int. 1997,
29, 33–62, and 63–115.
9. Gothelf, K. V.; Jorgensen, K. A. Chem. Rev. 1998, 863–
909.
10. Robin, S.; Rousseau, G. Eur. J. Org. Chem. 2002, 3099–
3114.
11. Tiecco, M.; Testaferri, L.; Bagnoli, L.; Marini, F.; Santi,
C.; Temperini, A. Heterocycles 1996, 43, 2679–2686;
Tiecco, M.; Testaferri, L.; Tingoli, M.; Bagnoli, L.;
Marini, F. J. Chem. Soc., Perkin Trans. 1 1993, 1989–
1993.
12. Shaw, R. W.; Lathbury, D. C.; Bates, P. A.; Hurthouse,
M. B.; Gallagher, T. J. Chem. Soc., Perkin Trans. 1 1989,
2415–2424.
129.7, 128.2, 66.9, 53.67, 37.9, 34.1, 32.5, 30.3, 24.6, 21.96,
21.7. MS m/z (%) (ES): 308 (MH-Br, 100). IR (NaCl,
cmꢀ1): 2960, 2930, 1650. Compound (6b): the product
(87%) was obtained as a pale yellow thick oil. 1H NMR dH
(300 MHz, CDCl3): 7.65–7.61 (m, 2H, ArH), 7.30–7.29
(m, 3H, ArH), 7.27 (s, 1H, CH@N), 4.27 (m, 1H, NCH),
3.33 (dd, 1H, J 12.4 and 3.5 Hz, HCHSe), 3.01 (dd, 1H, J
12.4 and 6.0 Hz, HCHSe), 2.04 (dd, 1H, J 13.0 and 8.0 Hz,
HCHCHN), 1.78–1.32 (m, 11H, HCHCHN and (CH2)5).
13C NMR dC (75 MHz, CDCl3): 174.7, 132.6, 131.60
(2CH–Ar), 129.2, 129.1, 71.8, 55.3, 40.1, 35.4, 34.7, 33.2,
25.6, 23.1, 23.0. MS m/z (%) (ES): 308(M+1, 100). IR
(NaCl, cmꢀ1): 2965, 2929, 1625. Compound (7b): the
1
product (84%) was obtained as a colourless thick oil. H
13. Lathbury, D. C.; Shaw, R. W.; Anderson, M.; Gallagher,
T. J. Chem. Soc., Perkin Trans. 1 1991, 659–660.
14. (a) Salomons, G.; Ghost, S. Org. Synth. 1990, Coll. Vol. 7,
177–181; (b) Brannock, K. C. J. Am. Chem. Soc. 1959, 81,
3379–3383.
15. (a) Liu, G.; Cogan, D. A.; Ellman, J. A. J. Am. Chem. Soc.
1997, 119, 9913–9914; (b) Cogan, D. A.; Liu, G.; Kim, K.;
Backes, B. J.; Ellman, J. A. J. Am. Chem. Soc. 1998, 120,
8011–8019; (c) Cogan, D. A.; Ellman, J. A. J. Am. Chem.
Soc. 1999, 121, 268–269.
NMR dH (300 MHz, CDCl3): 7.49–7.48 (m, 2H, ArH),
7.23–7.21 (m, 3H, ArH), 3.36 (m, 1H, NCH), 3.04–3.03
(m, 2H, HCH2Se), 2.81 and 2.82 (2 · d, 2H, J 10.4 Hz,
CH2N), 2.33 (br, NH), 1.82 (dd, 1H, J 12.0 and 5.9 Hz,
HCHCH), 1.41–1.31 (m, 10H, (CH2)5), 1.21 (dd, 1H, J
12.0 and 3.1 Hz, HCHCH). 13C NMR dC (75 MHz,
CDCl3): 132.5, 130.6, 129.1, 128.8, 58.5, 57.9, 45.1, 43.9,
38.3, 37.0, 35.0, 31.5, 26.8, 23.9. MS m/z (%) (ES): 310
(M+1, 100). IR (NaCl, cmꢀ1): 3333, 2950, 1470. Com-
pound (10b): the product was obtained as a white
amorphous solid in quantitative yield. 1H NMR dH
(300 MHz, CDCl3): 8.04 (br, 2H, +NH2), 7.92–7.90 (m,
2H, ArH), 7.28–7.26 (m, 3H, ArH), 3.83 (m, 1H, NCH),
3.51 (dd, 1H, J 13.7 and 3.7 Hz, HCHSe), 3.38–3.17 (m,
3H, HCHSe and CH2NH), 2.09 (dd, 1H, J 12.7 and
6.1 Hz, HCHCH), 1.63–1.03 (m, 11H, HCHCH and
(CH2)5). 13C NMR dC (75 MHz, CDCl3): 134.0 129.5,
128.3, 128.0, 59.24, 54.9, 43.0, 42.8, 36.9, 35.5, 31.0, 25.5,
23.6, 22.9. MS m/z (%) (ES): 310 (MHꢀCl, 100). IR
(NaCl, cmꢀ1): 3432, 2925, 1454.
16. Barrow, J. C.; Ngo, P. L.; Pellicore, J. M.; Selnich, H. G.;
Nantermet, P. G. Tetrahedron Lett. 2001, 42, 2051–2054.
17. General procedure for the cascade PhSeBr-induced cycli-
sation of sulfinylimines: Phenylselenyl bromide (1.0 mmol)
in 5 ml of dry solvent (CH2Cl2 or MeCN) was added
dropwise to a stirred solution of tert-butanesulfinylimine
(3) (1 mmol) in the same solvent (10 ml) at 0 ꢁC under
nitrogen atmosphere, and stirring was continued at room
temperature for 18–22 h. The solvent was then evaporated
under vacuum to give the iminium salt (5). The iminium
salt (5) was treated with 2 N aq NaOH and extracted with
CH2Cl2 (two times), dried (MgSO4) and the solvent was
evaporated (at room temperature) under reduced pressure
to give the cyclic imines (6), which were further purified by
short flash chromatography eluting with ether to give a
pale yellow thick oil. These imines (6) can be reduced by
LiAlH4 (ether, reflux, 12 h) or NaBH4 (CH2Cl2/MeOH,
1:1 rt, 8 h) to afford the desired pyrrolidines (7). The
iminium salts (5) can also be reduced with sodium
borohydride (2 equiv) in 1:1 (v/v) methanol/CH2Cl2 at
room temperature for 8 h. Removal of the solvent under
reduced pressure afforded the crude pyrrolidines (7), which
were purified by flash chromatography on silica gel.
Diphenyldiselenide was first eluted by ether. The pyrrol-
idines (7) were next eluted with EtOAc/CH2Cl2 (4:1) to
give the desired cyclic and spirocyclic pyrrolidines (7) as a
colourless thick oil. These pyrrolidines when treated with
dry HCl in 4:1 ether/CH2Cl2 afforded the pyrrolidinium
salts (8) in quantitative yield. Compound (5b): The
product (100%) was obtained as a pale brown thick oil.
1H NMR dH (300 MHz, CDCl3): 9.92 (br s, 1H, CH@N+),
7.59–7.58 (m, 2H, ArH), 7.30–7.29 (m, 3H, ArH), 6.91 (br,
1H, NH), 4.71 (m, 1H, NCH), 3.68 (dd, 1H, J 13.5 and
3.65 Hz, HCHSe), 3.10 (dd, 1H, J 13.4 and 6.6 Hz,
HCHSe), 2.37 (dd, 1H, J 13.3 and 8.6 Hz, HCHCHN),
1.84 (dd, 1H, J 13.3 and 5.1 Hz, HCHCHN), 1.80–1.30
(m, 10H, (CH2)5). 13C NMR dC: 185.01, 133.63, 131.5,
18. General procedure for the cascade PhSeBr-induced cycli-
sation of sulfinylamides: Phenylselenyl bromide
(1.05 mmol) in 5 ml of dry (CH2Cl2) was added dropwise
to a stirred solution of tert-butanesulfinamide (1 mmol) in
CH2Cl2 (10 ml) at 0 ꢁC under nitrogen atmosphere and
stirring was continued at room temperature for 16–20 h.
The solvent was then evaporated under vacuo to give
ammonium salts (12). The salts were then treated with 2 N
aq NaOH and extracted with CH2Cl2 (two times), the
combined extracts were dried (MgSO4) and the solvent
was evaporated under reduced pressure to give the
pyrrolidines (7), which were further purified by flash
chromatography on silica gel. Diphenyldiselenide was first
eluted by diethyl ether. The pyrrolidines (7) were next
eluted with EtOAc/CH2Cl2 (4:1) to give the desired cyclic
and spirocyclic pyrrolidines (7) as colourless thick oil.
Compound (12b): the product was obtained as a yellow
thick oil in quantitative yield. 1H NMR dH (300 MHz,
CDCl3): 9.17 and 9.61 (2 · br, 2H, +NH2), 7.70–7.54 (m,
2H, ArH), 7.29–7.27 (m, 3H, ArH), 3.80 (m, 1H, NCH),
3.54 (dd, 1H, J 13.7 and 3.7 Hz, HCHSe), 3.21–3.12 (m,
3H, HCHSe and CH2NH), 2.11 (dd, 1H, J 12.7 and
6.1 Hz, HCHCH), 1.59–1.13 (m, 11H, HCHCH and
(CH2)5). 13C NMR dC (75 MHz, CDCl3): 134.0, 131.60,
129.5, 128.04, 59.34, 54.8, 43.0, 42.7, 36.9, 35.5, 30.6, 25.4,
23.6, 22.9. MS m/z (%) (ES): 310 (MHꢀBr, 100); IR
(NaCl, cmꢀ1): 3430, 2925, 1476.